Home Newsfeeds Redburn Partners Reinstates Neutral on Omnicom Group

Redburn Partners Reinstates Neutral on Omnicom Group

Redburn Partners analyst Bianca Dallal reinstates Omnicom Group (NYSE:OMC) with a Neutral.

byBenzinga Newsdesk

September 8, 2022

1 minute read

Redburn Partners analyst Bianca Dallal reinstates Omnicom Group (NYSE:OMC) with a Neutral.

Oprah Winfrey Backed Oatly, But The Short Seller Target Is Losing More Analyst Support

By Priya Nigam

September 13, 12:17 PM

Oatly Group (NASDAQ: OTLY) faces a consumer environment that is likely to become “particularly volatile” in Europe and Asia, according to Credit Suisse.

OTLY

Why Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today?

By Vandana Singh

December 4, 9:29 AM

EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) announced topline results of its Phase 2 DAVIO 2 trial of EYP-1901, an investigational sustained delivery maintenance treatment for wet age-related macular degeneration (wet AMD) combining vorolanib, a selective tyrosine kinase inhibitor with

EYPT

Sientra Announces 1-For-10 Reverse Stock Split

By Benzinga Newsdesk

January 20, 10:25 AM

Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or the "Company"), a medical aesthetics company uniquely focused on plastic surgeons, today announced that its Board of Directors has approved a 1-for-10

SIEN

BMO Capital Maintains Outperform on Splunk, Lowers Price Target to $100

By Benzinga Newsdesk

December 1, 9:55 AM

BMO Capital analyst Keith Bachman maintains Splunk (NASDAQ:SPLK) with a Outperform and lowers the price target from $120 to $100.

SPLK

Redburn Partners Reinstates Neutral on Omnicom Group

Related Posts

Oprah Winfrey Backed Oatly, But The Short Seller Target Is Losing More Analyst Support

Why Is Age-Related Blindness Focused EyePoint Pharmaceuticals Stock Trading Over 300% Today?

Sientra Announces 1-For-10 Reverse Stock Split

BMO Capital Maintains Outperform on Splunk, Lowers Price Target to $100